PSA Screenings Under Attack

July 19, 2012

The Jewish Exponent reports on the recent controversial study by the U.S. Preventative Services Task Force questioning the use of a prostate-specific antigen (PSA) test in saving the lives of those with prostate cancer. The American Association of Clinical Urologists and American Urological Association "are vigorously opposed to a blanket recommendation against screening," explains Alan Wein, MD, chair of the division of Urology. "On a personal basis, I am against the findings and the D-1 rating they assigned against PSA blood tests as well," said Wein, about the rating that marks when the cancer has entered the lymph nodes only.

Jewish Exponent article

Learn about cutting-edge treatment for prostate cancer

Prostate Cancer Treatment at Penn